Pair of Controversial EPA Science Bills Head to Senate
Last week, the full House of Representatives debated two controversial bills that could have a significant impact on how the Environmental Protection Agency uses and reviews scientific information: the “Honest and Open New EPA Science Treatment (HONEST) Act”
The former would prevent EPA from taking various regulatory actions unless the scientific information relied upon is “publicly available online in a manner that is sufficient for independent analysis and substantial reproduction of research results.” The latter would overhaul the membership criteria and public comment procedures of EPA’s Science Advisory Board
The primary stated purpose of the bills is to ensure the agency relies on research that is transparent and reproducible and to increase the diversity of perspectives represented on the SAB by increasing local and industry representation. However, critics maintain that the bills would likely prevent the agency from using large swaths of peer-reviewed literature and would unduly bar certain highly qualified academics from the SAB.
Bills land in Senate for the third time
The Republican-controlled chamber passed the bills last week on votes of 228 to 194
The House passed similar bills on mostly partly-line votes in the past two Congresses, and each elicited a veto
Senate Republicans have been receptive to the legislation in the past, as the Senate Environment and Public Works Committee considered companion bills in 2015 — one of which cleared
Honest attempt at reform or ‘insidious’ effort?
“The days of ‘trust-me science’ are over,” declared Rep. Lamar Smith (R-TX), chair of the House Science Committee and sponsor of the “HONEST Act,” near the outset of the March 29 floor debate
In our modern information age, federal regulations should be based only upon data that is available for every American to see and that can be subjected to independent review. That is called the scientific method.
Smith also asserted that the bill’s new provision requiring redaction of personal and proprietary information should allay privacy concerns, an oft-raised objection to the earlier bills.
Rep. Eddie Bernice Johnson (D-TX), ranking member of the House Science Committee, denounced the bill as no better than its prior incarnation, the “Secret Science Reform Act:”
The secret science bills that the Republicans tried to enact over the previous two Congresses were insidious bills designed from the outset to prevent the EPA from using the best available science to meet its obligations under the law.
Furthermore, she was unconvinced that the new redaction provision would adequately protect private information since the bill would permit anyone to access it if they secured a confidentiality agreement from the EPA administrator.
Johnson also disputed the proponents’ invocation of the scientific method.
“Republicans claim that this bill is just implementing scientific best practices. It is odd, then, that a host of scientific societies and science stakeholder groups have expressed their opposition to this legislation,” she said, citing a letter
In the document, the organizations express concern about how certain terms in the bill could be interpreted and argue that its insistence on reproducibility is misguided. Depending on the reproducibility criteria adopted, they say, the bill could prevent EPA from using research that is infeasible or impossible to reproduce, such as longitudinal public health studies and research based on one-time events like the Deepwater Horizon oil spill.
Cost estimate a focal point of debate
Critics of the “HONEST Act” took issue with the vote being scheduled before the Congressional Budget Office (CBO) released its analysis of the bill. Given its absence, they pointed to CBO’s 2015 estimate
Smith countered that this estimate was based on a “misinterpretation” of the bill’s requirements. “All the HONEST Act requires is that the EPA use science that is publicly available, not make all science public itself. So the cost is negligible,” he said.
CBO posted its analysis
“Based on information from officials at the EPA about how the agency would implement the legislation, CBO expects that the agency would choose to rely only on studies that already meet the act’s requirements at the outset of undertaking covered actions.” CBO estimates that this implementation method would cost about $5 million between 2018 and 2022.
However, CBO also notes that such an approach would significantly decrease the number of studies EPA uses — currently about 50,000 per year. CBO estimates that if EPA were to continue to use this volume of research, the agency would need to spend at least $100 million per year to “upgrade the format and availability of those studies’ data to the level required” by the bill.
Democratic lawmakers have begun to question the CBO analysis after Bloomberg BNA reported
Sen. Tom Carper (D-DE), ranking member of the Senate Environment and Public Works Committee, sent a letter
A balancing act?
The “EPA Science Advisory Board Reform Act” would alter the membership composition of the SAB in three primary ways. First, it would require that at least 10 percent of the board be drawn from state, local, or tribal governments. Second, it would make it easier for industry experts to serve as members. Finally, it would prevent current recipients of EPA grants from serving on the board and would bar departing members from receiving EPA grants for three years.
During the March 30 floor debate
“Unfortunately, the history of the SAB shows that private sector representation is often lacking or simply nonexistent,” he remarked. He also argued that the service of EPA grant recipients on the board could, at the very least, “create the appearance of a conflict of interest.”
Johnson blasted the grant recipient restrictions, asserting that they amount to deliberate “roadblocks” to academic scientists serving on the board. She asserted that the provision “turn[s] the term ‘conflict of interest’ on its head by excluding scientists who have done the most relevant research on the topic being considered by the board.” Conversely, she argued the bill “gut[s] actual financial conflict-of-interest restrictions against industry representatives.”
Regardless of its ultimate composition, it appears the SAB will likely have a lighter workload in the coming years. After the vote on the bill, the Washington Post reported